A PROSPECTIVE, OPEN-LABEL, MULTICENTER STUDY OF THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF THERAPURE PLASMACAP IG IN ADULTS AND CHILDREN WITH PRIMARY IMMUNE DEFICIENCY DISEASES
- Registry ID
- TBI-001-IGIV
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- THERAPURE BIOPHARMA INC.
- Start date
- 2018-02-27
- Completion date
- 2019-06-25
- Last update
- 2017-07-18
Conditions
- PRIMARY IMMUNE DEFICIENCY
View on source registry